Post-market Clinical Follow-up of the SRS Implant
National, Multicentre Observational Study on Surgical Reconstruction of the Anterior and Apical Compartment of the Pelvic Floor With a Single-incision, Fixation-free Self-Retaining Support Implant (SRS Implant)
1 other identifier
observational
175
1 country
7
Brief Summary
National, multicentre observational study on surgical reconstruction of the anterior and apical compartment of the pelvic floor with an SRS implant
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2022
Longer than P75 for all trials
7 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 9, 2021
CompletedFirst Posted
Study publicly available on registry
December 27, 2021
CompletedStudy Start
First participant enrolled
April 7, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2026
ExpectedApril 2, 2025
March 1, 2025
3.4 years
December 9, 2021
March 28, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Patient´s Quality of Life
Evaluation of changes in quality of life twelve months after implantation of the SRS implant compared to baseline. Quality of Life was assessed by the P-QOL (Prolapse Quality of Life Questionnaire). The P-QOL yields a domain score in the range from zero to 100, wheras a score of zero is the best.
12 months
Study Arms (1)
SRS implant
Surgical reconstruction of the anterior and apical compartment of the pelvic floor with an SRS implant
Eligibility Criteria
Women with a symptomatic anterior vaginal wall prolapse with/without apex/uterine prolapse ≥ stage II (according to POP-Q system), transvaginal SRS implantation for pelvic organ prolapse surgery
You may qualify if:
- Women with a symptomatic anterior vaginal wall prolapse with/without apex/uterine prolapse ≥ stage II (according to POP-Q system). This applies to primary as well as recurrent intervention.
- Age ≥ 21 years.
- Patient is mentally able to understand the nature, aims, or possible consequences of the PMCF study.
- Patient information has been provided and written consent exists.
You may not qualify if:
- Contraindications according to the manufacturer's instructions for use.
- Patient with previous urogynaecological surgeries with alloplastic material.
- Patient with radiological treatment in the pelvic floor.
- Patient is institutionalised by court or official order (MPDG §27).
- Participation in another interventional study concerning pelvic floor reconstruction.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- pfm medical gmbhlead
Study Sites (7)
Heilig Geist-Hospital
Bensheim, Hesse, 64625, Germany
Universitätsklinikum Augsburg
Augsburg, 86156, Germany
Evangelisches Krankenhaus Hagen-Haspe
Hagen, 58135, Germany
Asklepios Klinik Altona
Hamburg, 22763, Germany
Städtisches Krankenhaus Kiel
Kiel, 24116, Germany
Marienhaus Klinikum Hetzelstift Neustadt/Weinstraße
Neustadt, 67434, Germany
Klinikum Oberlausitzer Bergland gGmbH
Zittau, 02763, Germany
Related Publications (2)
Levy G, Padoa A, Marcus N, Beck A, Fekete Z, Cervigni M. Anchorless implant for the treatment of advanced anterior and apical vaginal prolapse - Medium term follow up. Eur J Obstet Gynecol Reprod Biol. 2020 Mar;246:55-59. doi: 10.1016/j.ejogrb.2020.01.005. Epub 2020 Jan 9.
PMID: 31954369BACKGROUNDLevy G, Padoa A, Fekete Z, Bartfai G, Pajor L, Cervigni M. Self-retaining support implant: an anchorless system for the treatment of pelvic organ prolapse-2-year follow-up. Int Urogynecol J. 2018 May;29(5):709-714. doi: 10.1007/s00192-017-3415-3. Epub 2017 Jul 14.
PMID: 28710613BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tina Cadenbach-Blome, Dr. med.
Asklepios Klinik Altona
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 9, 2021
First Posted
December 27, 2021
Study Start
April 7, 2022
Primary Completion
September 1, 2025
Study Completion (Estimated)
September 1, 2026
Last Updated
April 2, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share